Form 8-K - Current report:
SEC Accession No. 0001104659-24-090153
Filing Date
2024-08-15
Accepted
2024-08-15 17:00:13
Documents
17
Period of Report
2024-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421653d1_8k.htm   iXBRL 8-K 33326
2 EXHIBIT 10.1 tm2421653d1_ex10-1.htm EX-10.1 35887
3 EXHIBIT 99.1 tm2421653d1_ex99-1.htm EX-99.1 11056
7 GRAPHIC tm2421653d1_ex10-1img001.jpg GRAPHIC 23752
8 GRAPHIC tm2421653d1_ex99-1img01.jpg GRAPHIC 2388
  Complete submission text file 0001104659-24-090153.txt   306861

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA armp-20240731.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20240731_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20240731_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2421653d1_8k_htm.xml XML 3547
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 241213242
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)